Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fabien Dorange"'
Autor:
Guillaume Corre, Ababacar Seye, Sophie Frin, Maxime Ferrand, Kathrin Winkler, Cyril Luc, Fabien Dorange, Céline J. Rocca, Anne Galy
Publikováno v:
Gene therapy. 29(9)
With an increasing number of gene therapy clinical trials and drugs reaching the market, it becomes important to standardize the methods that evaluate the efficacy and safety of gene therapy. We herein report the generation of lentiviral standards wh
Autor:
Fabien Dorange
Publikováno v:
Cell and Gene Therapy Insights. 5:1557-1560
Autor:
Christine Le Bec, Fabien Dorange
Publikováno v:
Cell & Gene Therapy Insights
Cell & Gene Therapy Insights, 2018, Latest development in viral & non-viral vector manufacturing, pp.119-129. ⟨10.18609/cgti.2018.015⟩
Cell & Gene Therapy Insights, 2018, Latest development in viral & non-viral vector manufacturing, pp.119-129. ⟨10.18609/cgti.2018.015⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139f8bc0806b0e2b71d991d2a50c08f3
https://hal.archives-ouvertes.fr/hal-02880795
https://hal.archives-ouvertes.fr/hal-02880795
Autor:
Valérie Caro, Fabien Dorange, Justine Cheval, Ana Maria Burguiere, Nicolas Dumey, Claude Jean Manuguerra, Ghislaine Guigon, Kevin Pariente, Nicolas Berthet, Lionel Frangeul, Marc Eloit, Marc Lecuit, Claudine Rousseaux, Ivan Moszer, Hervé Bourhy, Sylvain Brisse, Virginie Sauvage, Laurent Dacheux
Publikováno v:
Journal of Clinical Microbiology
Journal of Clinical Microbiology, 2011, 49 (9), pp.3268-3276. ⟨10.1128/JCM.00850-11⟩
Journal of Clinical Microbiology, American Society for Microbiology, 2011, 49 (9), pp.3268-3276. ⟨10.1128/JCM.00850-11⟩
Journal of Clinical Microbiology, 2011, 49 (9), pp.3268-3276. ⟨10.1128/JCM.00850-11⟩
Journal of Clinical Microbiology, American Society for Microbiology, 2011, 49 (9), pp.3268-3276. ⟨10.1128/JCM.00850-11⟩
High-throughput sequencing furnishes a large number of short sequence reads from uncloned DNA and has rapidly become a major tool for identifying viruses in biological samples, and in particular when the target sequence is undefined. In this study, w
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2002, 76 (4), pp.1959-1970
Journal of Virology, American Society for Microbiology, 2002, 76 (4), pp.1959-1970
Experiments were conducted to investigate the roles of Marek's disease virus serotype 1 (MDV-1) major tegument proteins VP11/12, VP13/14, VP16, and VP22 in viral growth in cultured cells. Based on a bacterial artificial chromosome clone of MDV-1 (BAC
Publikováno v:
BMC Proceedings
BMC Proceedings, Vol 5, Iss Suppl 8, p P127 (2011)
BMC Proceedings, Vol 5, Iss Suppl 8, p P127 (2011)
Background Mycoplasma testing on cell lines or biological products used to be performed based on classical methods such as agar and broth medium and/or indicator cell culture. However, these methods require a long incubation period and are not adapte
Publikováno v:
The journal of gene medicine. 6(9)
Background Semliki Forest virus (SFV) vectors have a great potential for the induction of protective immunity in a large number of clinical conditions including cancer. Such a potential accounts for the huge efforts made to improve the in vivo expres
Autor:
Slimane El Mehdaoui, Fabien Dorange, Pierre Coursaget, Chantal Pichon, Jean-François Vautherot
Publikováno v:
Journal of General Virology
Journal of General Virology, Microbiology Society, 2000, 81, pp.2219-2230
Journal of General Virology, Microbiology Society, 2000, 81 (9), pp.2219-2230. ⟨10.1099/0022-1317-81-9-2219⟩
Journal of General Virology, 2000, 81 (9), pp.2219-2230. ⟨10.1099/0022-1317-81-9-2219⟩
Journal of General Virology, Microbiology Society, 2000, 81, pp.2219-2230
Journal of General Virology, Microbiology Society, 2000, 81 (9), pp.2219-2230. ⟨10.1099/0022-1317-81-9-2219⟩
Journal of General Virology, 2000, 81 (9), pp.2219-2230. ⟨10.1099/0022-1317-81-9-2219⟩
Genes UL49 and UL48 of Marek’s disease virus 1 (MDV-1) strain RB1B, encoding the respective homologues of herpes simplex virus type 1 (HSV-1) genes VP22 and VP16, were cloned into a baculovirus vector. Seven anti-VP22 MAbs and one anti-VP16 MAb wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ab5e4ad4c188edd8f1c8258372b04a
https://hal.inrae.fr/hal-02686317
https://hal.inrae.fr/hal-02686317
Autor:
Brian S. Baier, Christine Mitchell, Fabien Dorange, Indira Hewlett, Heather D. Malicki, David Wall, Philip D. Minor, Catherine Anscombe, Wenping Sun, Erika Muth, Chiara Modena, Birgit Ottenwälder, Eric Delwart, Jean-Louis Ruelle, Christiane Hill, Jean-Pol Cassart, Saheer E. Gharbia, Stacey Hargrove, Florence Jagorel, Viswanath Ragupathy, Lucy Gisonni-Lex, Edward Mee, Linlin Li, Voskanian-Kordi Alin, Samia N. Naccache, Siemon H. S. Ng, Laurent Mallet, Edward T. Mee, Daniel C. Richter, Fabio La Neve, Jenny Nguyen, Arman Tehrani, Mark D. Preston, Matthew Cotten, David J. Wooldridge, Olivier Vandeputte, Xuening Huang, Justine Cheval, Lia van der Hoek, Graham Rose, Raju Misra, Marc Eloit, Vahan Simonyan, Avisek Deyati, Silke Schepelmann, Paul Kellam, Nicolas Mermod, Mark Preston, George Xu, Charles Y. Chiu, Thomas Fu, Li Li, Carine Letellier, Robert L. Charlebois, Colette Cote, Weber-Lehmann Jacqueline, Arnaud Lamamy
Publikováno v:
Vaccine
Vaccine, 34(17), 2035-2043. Elsevier BV
Vaccine, vol. 34, no. 17, pp. 2035-2043
Vaccine, 34(17), 2035-2043. Elsevier BV
Vaccine, vol. 34, no. 17, pp. 2035-2043
Highlights • Deep sequencing has potential as an improved adventitious virus screening method. • 15 laboratories sequenced a common reagent containing 25 target viruses. • 6 viruses were detected by all lab, the remainder were detected by 4–1